Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations. If you cannot find what you are looking for, do not hesitate to get in touch with us.



Interim Report Q3 2020

Oncopeptides AB (publ) released its interim report for Q3 2020 on November 19, 2020.